Core Scientific (CORZ) Gains from Investment Securities (2022 - 2026)

Core Scientific has disclosed Gains from Investment Securities across 4 years of filings, most recently posting $1.0 billion for Q2 2026.

• In Q2 2026, Gains from Investment Securities rose 13.3% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $822.9 million (up 30.91% YoY), while the FY2025 annual figure was $34.0 million, down 97.66% from the prior year.
• Gains from Investment Securities came in at $1.0 billion for Q2 2026 at Core Scientific, up from $31.8 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.0 billion in Q2 2026 to a low of -$634.3 million in Q1 2025.
• Average Gains from Investment Securities over 4 years is $158.8 million, with a median of $15.7 million recorded in 2022.
• Year-over-year, Gains from Investment Securities tumbled 3349.16% in 2025 and surged 105.02% in 2026.
• Over 4 years, Gains from Investment Securities stood at -$5.0 million in 2022, then soared by 4692.79% to $227.4 million in 2024, then slumped by 245.55% to -$331.0 million in 2025, then soared by 416.14% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Gains from Investment Securities figures were $1.0 billion in Q2 2026, $31.8 million in Q1 2026, and -$331.0 million in Q4 2025.